Enumeral Biomedical Holdings, Inc. Uncategorized Contracts & Agreements
41 Contracts & Agreements
- Amendment No. 2 to Study Agreement, dated as of May 31, 2017, between Enumeral Biomedical Holdings, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on August 14, 2017)
- Amendment No. 1 to Letter Agreement, dated as of June 9, 2017, between Arthur H. Tinkelenberg, Ph.D. and Enumeral Biomedical Holdings, Inc (Filed With SEC on June 14, 2017)
- AMENDMENT TO AMENDED AND RESTATED WARRANTS TO PURCHASESTOCK (Filed With SEC on December 12, 2016)
- 200 CambridgePark Drive · Suite 2000 · Cambridge, MA 02140 · O: 617 ###-###-#### (Filed With SEC on November 10, 2016)
- FOURTH AMENDMENT (Filed With SEC on May 13, 2016)
- 200 CambridgePark Drive · Suite 2000 · Cambridge, MA 02140 · O: 617 ###-###-#### (Filed With SEC on March 30, 2016)
- 200 CambridgePark Drive · Suite 2000 · Cambridge, MA 02140 · O: 617 ###-###-#### (Filed With SEC on March 30, 2016)
- AMENDMENT NO. 1 TO STUDY AGREEMENT Between Merck Sharp & Dohme Corp. and Enumeral Biomedical Holdings Inc. (Filed With SEC on March 30, 2016)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on May 15, 2015)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on November 14, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on October 31, 2014)
- FIRST AMENDMENT (Filed With SEC on October 31, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on October 31, 2014)
- Exhibit A Target Milestones (Filed With SEC on August 8, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 8, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 8, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 8, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 8, 2014)
- SECOND AMENDMENT (Filed With SEC on August 8, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 8, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 8, 2014)
- ENUMERALBIOMEDICAL HOLDINGS, INC. 2014 EquityIncentive Plan July 31,2014 (Filed With SEC on August 8, 2014)
- PLACEMENT AGENCYAGREEMENT (Filed With SEC on August 8, 2014)
- LOCK-UP AGREEMENT (Filed With SEC on August 8, 2014)
- General RELEASEagreement (Filed With SEC on August 8, 2014)
- SPLIT-OFF AGREEMENT (Filed With SEC on August 8, 2014)
- Exhibit A Target Milestones (Filed With SEC on August 7, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 7, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 7, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 7, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 7, 2014)
- SECOND AMENDMENT (Filed With SEC on August 7, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 7, 2014)
- Portions of this document have been redactedpursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 underthe... (Filed With SEC on August 7, 2014)
- ENUMERALBIOMEDICAL HOLDINGS, INC. 2014 EquityIncentive Plan July 30,2014 (Filed With SEC on August 7, 2014)
- PLACEMENT AGENCYAGREEMENT (Filed With SEC on August 7, 2014)
- LOCK-UP AGREEMENT (Filed With SEC on August 7, 2014)
- General RELEASEagreement (Filed With SEC on August 7, 2014)
- SPLIT-OFF AGREEMENT (Filed With SEC on August 7, 2014)
- PLAN OF CONVERSION OF ceruleangroup, inc., a Nevada corporation into EnumeralBiomedical HOLDINGS, INC., a Delaware corporation (Filed With SEC on July 16, 2014)
